HighGravityDataAxon Enterprise — Nov 7, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001069183-24-000055
Showing in the filing
Expected stock-based compensation expense related to the broad-based 2024 eXponential Stock Plan and the 2024 CEO Performance Award
“Approximately $170 million”
Period
FY2024
Measure
Company-defined measure
Source
Prose
All guidance in this release · 16
Adjusted EBITDA margin for FY2024
“approximately 24.6%”
Revenue for Q4 FY2024
“$560 million to $570 million”
Adjusted EBITDA for Q4 FY2024
“$130 million to $135 million”
Revenue expectation for FY2024
“approximately $2.07 billion”
Software-only gross margin target for the long term
“80%”
Portion of total company future contracted r…
“between 15% to 25%”
Adjusted EBITDA margin for Q4 FY2024
“approximately 23.5%”
Adjusted EBITDA margin for Q4 FY2024
“approximately 23.5%”
Adjusted EBITDA for FY2024
“approximately $510 million”
Adjusted EBITDA dollars for FY2024
“approximately $510 million”
Stock-based compensation expenses for FY2024
“approximately $360 million to $380 million”
Stock-based compensation expense for broad-b… for FY2024
“approximately $210 million”
Expected stock-based compensation expense re… for FY2024
“Approximately $170 million”
Stock-based compensation expense related to … for FY2024
“Approximately $43 million”
CapEx for FY2024
“$80 million to $95 million”
Moonshot goal to cut gun-related deaths betw… for FY2033
“50%”
Exhibit 99.1 · the passage around this item
… earlier in the release
◦ Full year stock-based compensation expense includes approximately $210 million for broad-based equity compensation programs and a one-time enhanced equity compensation program provided to employees whose compensation is under a specific threshold. Approximately $170 million in full year expected stock-based compensation expense, primarily in SG&A and R&D, is related to the broad-based 2024 eXponential Stock Plan and the 2024 CEO Performance Award approved by our shareholders in May 2024. These performance-based incentive programs are achieved through stock price, operational and time-based requirements and are divided into seven substantially equal tranches. As of September 30, 2024, we have recognized expenses related to some tranches where we currently deem achievement to be probable. Approximately $43 million in expense, primarily in COGS, is related to a one-time enhanced equity compensation program provided to employees whose compensation is under a specified threshold. • We expect 2024 CapEx to be in the range of $80 million to $95 million, unchanged from prior quarters. Our 2024 CapEx plans include investments in TASER 10 automation and capacity expansion, including cartridge capacity, global facility build-out and upgrades, such as warehousing support for global shipping facilities. Quarterly conference call and webcast We will host our Q3 2024 earnings conference call webinar on Thursday, November 7, at 2 p.m. PT / 5 p.m. ET. The webcast wil
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.